Acción PURE PURE BIOSCIENCE, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas PURE Bioscience, Inc.

Acciones

PURE

US74621T2096

Diferido OTC Markets
Otros sitios de cotización
 17:45:16 27/06/2024 		Varia. Cinco días. Varia. 1 de enero.
0,0799 USD +30,98 % Gráfico intradía de PURE Bioscience, Inc. +6,53 % -38,40 %
06/05 PURE Bioscience nombra a Darin Zehr miembro del Consejo de Administración CI
18/03 PURE Bioscience, Inc. informa de los resultados del segundo trimestre y de los seis meses finalizados el 31 de enero de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
PURE Bioscience Announces an International Supply and License Agreement with AgroVet Alliance
PURE Bioscience Reports Fiscal Third Quarter 2024 Financial Results
PURE Bioscience Appoints Darin Zehr to Board of Directors
PURE Bioscience Appoints Darin Zehr to Board of Directors
PURE Bioscience, Inc. announced that it has received $3 million in funding
PURE Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024
PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
PURE Bioscience, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023
PURE Bioscience Reports Fiscal First Quarter 2024 Financial Results
PURE Bioscience, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023
PURE Bioscience Reports Fiscal 2023 Financial Results
PURE Bioscience to unveil “PURE Genius” Food Safety Program at the Annual International Association for Food Protection Meeting
PURE Bioscience, Inc. announced that it has received $1.8 million in funding
PURE Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
PURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial Results
PURE BIOSCIENCE, INC. : Change in Directors or Principal Officers (form 8-K)
Pure Bioscience, Inc. Announces CEO Changes
Pure Bioscience, Inc. Announces Management Changes
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results
PURE BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción PURE
  4. Noticias PURE Bioscience, Inc.
  5. Otros idiomas